IL-37 was elevated in some inflammatory diseases such as inflammatory bowel disease, atopic dermatitis, rheumatoid arthritis, and systemic lupus erythematosus [5–8], indicating IL-37 may have potential protective effect on inflammatory diseases. This evidence concerns the gene IL37 and systemic lupus erythematosus.